UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059601 |
|---|---|
| Receipt number | R000068182 |
| Scientific Title | Clarifying optimal exercise conditions for improving brain function |
| Date of disclosure of the study information | 2025/10/31 |
| Last modified on | 2025/10/31 11:54:02 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Clarifying optimal exercise conditions for improving brain function
Acronym
Clarifying optimal exercise conditions for improving brain function
Scientific Title
Clarifying optimal exercise conditions for improving brain function
Scientific Title:Acronym
Clarifying optimal exercise conditions for improving brain function
Region
| Japan |
Condition
Condition
Healthy subjects
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clarify whether there are optimal exercise conditions for each individual and function in improving brain function through exercise
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Brain function before and after acute exercise
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
3
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Other |
Interventions/Control_1
acute light intensity exercise
Interventions/Control_2
acute moderate intensity exercise
Interventions/Control_3
acute high intensity exercise
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 40 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1. Men and women aged 18 to under 40
2. Individuals who do not have any specific medical conditions and can be deemed healthy.
3. Individuals who, after receiving adequate explanation regarding participation in this study and with full comprehension, have provided written consent voluntarily.
Key exclusion criteria
1. Individuals who are a difference in vision between their left and right eyes of 0.5 or more
2. Individuals who are a history of specific underlying diseases (heart, arrhythmia, lung, brain, etc.) or related symptoms
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Takaaki |
| Middle name | |
| Last name | Komiyama |
Organization
The University of Osaka
Division name
Center for Education in Liberal Arts and Science
Zip code
560-0043
Address
1-16 Machikaneyama, Toyonaka, Osaka
TEL
06-6850-6972
komiyama.takaaki.celas@osaka-u.ac.jp
Public contact
Name of contact person
| 1st name | Takaaki |
| Middle name | |
| Last name | Komiyama |
Organization
The University of Osaka
Division name
Center for Education in Liberal Arts and Science
Zip code
560-0043
Address
1-16 Machikaneyama, Toyonaka, Osaka
TEL
06-6850-6972
Homepage URL
komiyama.takaaki.celas@osaka-u.ac.jp
Sponsor or person
Institute
The University of Osaka
Institute
Department
Personal name
Funding Source
Organization
Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Faculty of Education Research Ethics Committee in The University of Osaka
Address
1-1 Yamadaoka, Suita, Osaka
Tel
06-6879-4480
kensui-kensui-life@office.osaka-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 10 | Month | 31 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2022 | Year | 05 | Month | 10 | Day |
Date of IRB
| 2022 | Year | 10 | Month | 11 | Day |
Anticipated trial start date
| 2024 | Year | 02 | Month | 01 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 10 | Month | 31 | Day |
Last modified on
| 2025 | Year | 10 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068182
